Over 800 New York Auctions End Tomorrow 10/25 - Bid Now
Over 1300 Total Lots Up For Auction at Three Locations - OK 10/27, TX 10/28, CA 10/29

Q&A with Todd Ketch, CEO of the National Association for Proton Therapy

por Sean Ruck, Contributing Editor | March 06, 2017
Rad Oncology Proton Therapy
From the March 2017 issue of HealthCare Business News magazine

TK: There is significant international interest in proton therapy. New centers are being considered or built in Canada, the U.K., Middle East, China, India and many other countries. The opportunity to save and improve lives around the world is certainly significant and other countries want this option for their citizens.

HCB News: Has any staff been added to assist on your goals, or are there plans to add more staff for NAPT?
TK:
NAPT operates as efficiently as possible using a mix of staff and other management resources. There is growth happening in the industry and for NAPT, so we’ll continually assess the needs of the members and make resource decisions to meet those needs.

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs


HCB News: We always end with asking what your predictions are. So what do you predict the field of proton therapy will look like by 2027?
TK:
Proton therapy will continue to expand across the U.S. and the world. Institutions involved with cancer treatment recognize its significant benefits and are choosing to obtain the technology for their patients. Access to the therapy will continue to improve as the technology advances, improving the treatment and reducing the cost and other resource requirements. The number of lives saved and patients spared the difficulties of radiation side effects will expand as the clinical evidence builds and calls for coverage increase to the point where they can’t be denied.

Back to HCB News

You Must Be Logged In To Post A Comment